# Sepsis Post Market Observational Study and Potential Reduction of Time to Antibiotics - Baylor S&W

> **NCT04291417** · — · COMPLETED · sponsor: **Beckman Coulter, Inc.** · enrollment: 1700 (actual)

## Conditions studied

- Sepsis
- Adult Disease
- Emergency Department
- Severe Sepsis

## Interventions

- **DIAGNOSTIC_TEST:** CBC-DIFF Monocyte Volume Width Distribution (MDW)

## Key facts

- **NCT ID:** NCT04291417
- **Lead sponsor:** Beckman Coulter, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-20
- **Primary completion:** 2020-05-14
- **Final completion:** 2020-06-17
- **Target enrollment:** 1700 (ACTUAL)
- **Last updated:** 2021-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04291417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04291417, "Sepsis Post Market Observational Study and Potential Reduction of Time to Antibiotics - Baylor S&W". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04291417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*